{"description":"","height":1080,"html":"<div style=\"position:relative;padding-bottom:56.25%\"><iframe src=\"https://skiv.com/embed/BbRyHbJ\" style=\"width:100%;height:100%;position:absolute;left:0;top:0\" frameborder=\"0\" allow=\"fullscreen\" allowfullscreen></iframe></div>","provider_name":"Skiv","provider_url":"https://skiv.com","thumbnail_height":198,"thumbnail_url":"https://cdn.skiv.com/u/Y5cSHVc/624b411c77d07668432cf28bf0c5f256337b2d07a4aafeb37cd2e942a811ad4f/thumbnails/thumbnail.jpg","thumbnail_width":352,"title":"Part C Immunoexcitotoxicty Microglia activation -Summmary-Drug industry","type":"video","url":"https://skiv.com/v/BbRyHbJ","version":"1.0","width":1920}